Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-21-068261

Options or other derivatives

  • Director acquired 47,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Honig Peter · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-12-03 Grant or award : show line 1 in the form Nonstatutory Stock Option (right to buy) +47,800 $6.72 2031-12-02 47,800 47,800 D
Loading xslF345X03/doc4.xml…